Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
16.86
+0.72 (4.46%)
At close: Jun 26, 2026, 4:00 PM EDT
17.06
+0.20 (1.19%)
After-hours: Jun 26, 2026, 7:49 PM EDT

Company Description

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.

The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries.

The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.

It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates.

Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Schrödinger, Inc.
Schrödinger logo
Country United States
Founded 1990
IPO Date Feb 6, 2020
Industry Health Information Services
Sector Healthcare
Employees 850
CEO Ramy Farid

Contact Details

Address:
1540 Broadway, 24th Floor
New York, New York 10036
United States
Phone 212 295 5800
Website schrodinger.com

Stock Details

Ticker Symbol SDGR
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001490978
CUSIP Number 80810D103
ISIN Number US80810D1037
Employer ID 95-4284541
SIC Code 2834

Key Executives

Name Position
Dr. Ramy Farid Ph.D. Chief Executive Officer, President and Director
Dr. Karen Akinsanya Ph.D. President, Head of Therapeutics Research & Development and Chief Strategy Officer and Partnerships
Dr. Richard A. Friesner Ph.D. Co-Founder, Scientific Advisory Chairman and Director
Richie Jain Executive Vice President, Chief Financial Officer and Treasurer
Yvonne Tran Esq. Corporate Secretary, Chief Legal and People Officer
Prof. William Goddard III, Ph.D. Co-Founder and Scientific Advisor
Kenneth Patrick Lorton Executive Vice President, Chief Technology Officer and Chief Operating Officer of Software
Therese Abrams Principal Accounting Officer
Shane Brauner Executive Vice President and Chief Information Officer
Jaren Irene Madden Chief Corporate Affairs Officer and Head of Investor Relations

Latest SEC Filings

Date Type Title
Jun 23, 2026 8-K Current Report
Jun 8, 2026 8-K Current Report
May 20, 2026 8-K Current Report
May 15, 2026 SCHEDULE 13G/A Filing
May 5, 2026 10-Q Quarterly Report
May 5, 2026 8-K Current Report
May 1, 2026 144 Filing
Apr 30, 2026 SCHEDULE 13G/A Filing
Apr 29, 2026 SCHEDULE 13G Filing
Apr 28, 2026 ARS Filing